Octreotide LAR in the Induction of Immunologic Response in NENs Patients
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Evaluating the impact of OCTREOTIDE LAR on the immune response by studying Regulatory T-cell
(T-Reg) and Myeloid-derived suppressor cells (MDSC) and the immunoregulatory cell population
in peripheral blood of NET G1 / G2 patients treated with Octreotide LAR